title: Two intracellular signaling pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP.
abstract: As cerebral neurons express the dopamine D1 receptor positively coupled with adenylyl cyclase, together with the D3 receptor, we have investigated in a heterologous cell expression system the relationships of cyclic AMP with D3 receptor signaling pathways. In NG108-15 cells transfected with the human D3 receptor cDNA, dopamine, quinpirole, and other dopamine receptor agonists inhibited cyclic AMP accumulation induced by forskolin. Quinpirole also increased mitogenesis, assessed by measuring [3H]thymidine incorporation. This effect was blocked partially by genistein, a tyrosine kinase inhibitor. Forskolin enhanced by 50-75% the quinpirole-induced [3H]thymidine incorporation. This effect was maximal with 100 nM forskolin, occurred after 6-16 h, was reproduced by cyclic AMP-permeable analogues, and was blocked by a protein kinase A inhibitor. Forskolin increased D3 receptor expression up to 135%, but only after 16 h and at concentrations of > 1 microM. Thus, in this cell line, the D3 receptor uses two distinct signaling pathways: it efficiently inhibits adenylyl cyclase and induces mitogenesis, an effect possibly involving tyrosine phosphorylation. Activation of the cyclic AMP cascade potentiates the D3 receptor-mediated mitogenic response, through phosphorylation by a cyclic AMP-dependent kinase of a yet unidentified component. Hence, transduction of the D3 receptor can involve both opposite and synergistic interactions with cyclic AMP.
authors.affiliation: Unité de Neurobiologie et Pharmacologie, Centre Paul Broca de l'INSERM, Paris, France.
authors.forename: N
authors.initials: N
authors.lastname: Griffon
authors.forename: C
authors.initials: C
authors.lastname: Pilon
authors.forename: F
authors.initials: F
authors.lastname: Sautel
authors.forename: J C
authors.initials: JC
authors.lastname: Schwartz
authors.forename: P
authors.initials: P
authors.lastname: Sokoloff
mesh_terms: D002460:Cell Line; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology*; D018491:Dopamine Agonists / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D019833:Genistein; D006801:Humans; D007425:Intracellular Membranes / Q000502:physiology*; D007529:Isoflavones / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D019257:Quinpirole / Q000494:pharmacology; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D050637:Receptors, Dopamine D3; D015398:Signal Transduction; D013997:Time Factors
chemical_list: C493593:DRD3 protein, human; D018491:Dopamine Agonists; D004791:Enzyme Inhibitors; D007529:Isoflavones; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; D005576:Colforsin; D019257:Quinpirole; D019833:Genistein; D000242:Cyclic AMP; D011505:Protein-Tyrosine Kinases